Volitionrx (VNRX) Accumulated Expenses (2012 - 2025)

Volitionrx's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $4.2 million for Q4 2025.

• Quarterly Accumulated Expenses rose 21.14% year-over-year to $4.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 21.14% YoY) and the FY2025 annual result came in at $4.2 million, up 21.14% from the prior year.
• Accumulated Expenses was $4.2 million for Q4 2025 at Volitionrx, down from $4.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $4.6 million in Q3 2025 and bottomed at $2.7 million in Q1 2023.
• A 5-year average of $3.5 million and a median of $3.5 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses decreased 24.98% — and 2023, when it soared 36.78%.
• Volitionrx's Accumulated Expenses stood at $3.8 million in 2021, then fell by 24.98% to $2.9 million in 2022, then jumped by 36.78% to $3.9 million in 2023, then dropped by 11.5% to $3.5 million in 2024, then rose by 21.14% to $4.2 million in 2025.
• Business Quant data shows VNRX's Accumulated Expenses at $4.2 million in Q4 2025, $4.6 million in Q3 2025, and $4.4 million in Q2 2025.